Dante Labs Announces Worldwide Universal Access to Whole Genome Sequencing with 50% Off Black Friday Offering


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


NEW YORK, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced its Black Friday offer for whole genome sequencing test and interpretation at 50% off its already unbeatable list price, plus free worldwide shipping.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

"At Dante Labs, we believe in universal access to the most advanced technologies in genomics and personalized medicine," said Andrea Riposati, CEO of Dante Labs. "This Black Friday offering is a real step toward achieving that goal, driving down the cost of whole genome sequencing, on a global basis."

Dante's Whole Genome Test provides personalized insights on hundreds of areas through advanced interpretation of whole genome data through three advanced reports:

  • Wellness Report: actionable advice to live better
  • Nutrigenomics Report: personalized diet based on your genome
  • Genomic Fitness Report: personalized training program based on your genome

The offer is valid worldwide until Cyber Monday, Nov. 29, 2021.


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Special Black Friday Prices are:

About Dante Labs
Dante Labs is a global genomic data company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. Our assets include one of the largest private genome databases with research consent, a proprietary software platform designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Contact
Giorgio Lodi
media@dantelabs.com
+39 0862 191 0671
www.dantelabs.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c01a86ad-0c94-4db4-8256-844cdae819d9



27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: NewsPress ReleasesGeneral